ID   GH4T2
AC   CVCL_WX20
SY   GH4 T2
DR   Wikidata; Q93560965
RX   PubMed=1620544;
RX   PubMed=9388230;
RX   PubMed=11518800;
CC   Characteristics: Produced from a tumor produced by the passage of the parent cell line through female Wistar Furth rats (PubMed=1620544).
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
CC   Breed/subspecies: Wistar Furth.
DI   NCIt; C132194; Rat pituitary gland neoplasm
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0276 ! GH4C1
SX   Female
AG   7M
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 5
//
RX   PubMed=1620544;
RA   Conrad K.E., Gutierrez-Hartmann A.;
RT   "The ras and protein kinase A pathways are mutually antagonistic in
RT   regulating rat prolactin promoter activity.";
RL   Oncogene 7:1279-1286(1992).
//
RX   PubMed=9388230; DOI=10.1074/jbc.272.49.30852;
RA   Schweppe R.E., Frazer-Abel A.A., Gutierrez-Hartmann A., Bradford A.P.;
RT   "Functional components of fibroblast growth factor (FGF) signal
RT   transduction in pituitary cells. Identification of FGF response
RT   elements in the prolactin gene.";
RL   J. Biol. Chem. 272:30852-30859(1997).
//
RX   PubMed=11518800; DOI=10.1210/mend.15.9.0683;
RA   Jackson T.A., Schweppe R.E., Koterwas D.M., Bradford A.P.;
RT   "Fibroblast growth factor activation of the rat PRL promoter is
RT   mediated by PKCdelta.";
RL   Mol. Endocrinol. 15:1517-1528(2001).
//